| Business Summary | | Invivo
Corporation
designs,
manufactures
and
markets
monitoring
systems
that
measure
and
display
vital
signs
of
patients
in
medical
settings.
The
Company's
systems
simultaneously
monitor
heart
function,
respiration,
heart
rate,
blood
oxygen
levels,
invasive
and
non-invasive
blood
pressure
and
exhaled
carbon
dioxide
levels.
The
Company
developed
a
multi-parameter
vital
sign
patient
monitoring
system
for
use
during
magnetic
resonance
imaging
(MRI).
The
Company
has
made
inroads
into
the
general
patient
monitoring
market
with
its
Millennia
product
introduced
in
early
fiscal
1997.
In
addition
to
the
patient
monitoring
business,
the
Company
offers
a
line
of
safety
and
industrial
instrumentation
products. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Invivo
designs,
manufactures,
and
markets
monitoring
systems
that
measure
and
display
vital
signs
of
patients
in
medical
settings;
and
also
manufactures
and
markets
industrial
instrumentation
and
safety
application
products.
For
the
fiscal
year
ended
6/01,
sales
rose
3%
to
$54.3
million.
Net
income
fell
39%
to
$3.1
million.
Results
reflect
sales
of
MRI
vital
sign
monitoring
products,
offset
by
a
$601
thousand
loss
on
the
sale
of
G.C.
Industries
and
a
$415
thousand
reduction
on
gains
on
securities
sales. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Ernest Goggio, 77 Chairman | -- | -- | James Hawkins, 44 Pres,
CEO, Sec. | $312K | $680K | John Glenn, 39 CFO,
VP-Fin. | 189K | -- | F. Larry Young, 41 VP
of Operations | 184K | -- | Dollar
amounts are as of 30-June-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|